Target ligand expression on HUVECs by flow cytometry
Antibody (target) . | % positive HUVECs cultured on plastic (MFI)* . | % positive HUVECs cultured on gelatin (MFI)* . |
---|---|---|
P3 (negative control) | 2.3 ± 0.6 (113 ± 6.1) | 2 ± 0.6 (129 ± 8.3) |
Anti-αvβ3 | 49.7 ± 3.5 (127 ± 4.4) | 50 ± 2.5 (304 ± 19.8) |
Anti-CD44 | 6 ± 1.5 (121 ± 3.6) | 9 ± 3.5 (131 ± 8.2) |
Antithrombospondin† | 56.3 ± 3.5 (159 ± 8.1) | 87 ± 2.5 (800 ± 23) |
Antifibronectin† | 8.3 ± 1.5 (170 ± 4.6) | 59 ± 4 (693 ± 21.8) |
Anti–E-selectin† | 2.3 ± 0.6 (115 ± 7) | 37 ± 2.6 (252 ± 4.7) |
Anti–P-selectin | 1.7 ± 0.6 (108 ± 2.5) | 3 ± 0.6 (174 ± 3.6) |
Antibody (target) . | % positive HUVECs cultured on plastic (MFI)* . | % positive HUVECs cultured on gelatin (MFI)* . |
---|---|---|
P3 (negative control) | 2.3 ± 0.6 (113 ± 6.1) | 2 ± 0.6 (129 ± 8.3) |
Anti-αvβ3 | 49.7 ± 3.5 (127 ± 4.4) | 50 ± 2.5 (304 ± 19.8) |
Anti-CD44 | 6 ± 1.5 (121 ± 3.6) | 9 ± 3.5 (131 ± 8.2) |
Antithrombospondin† | 56.3 ± 3.5 (159 ± 8.1) | 87 ± 2.5 (800 ± 23) |
Antifibronectin† | 8.3 ± 1.5 (170 ± 4.6) | 59 ± 4 (693 ± 21.8) |
Anti–E-selectin† | 2.3 ± 0.6 (115 ± 7) | 37 ± 2.6 (252 ± 4.7) |
Anti–P-selectin | 1.7 ± 0.6 (108 ± 2.5) | 3 ± 0.6 (174 ± 3.6) |